• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖原贮积病 III 型的电诊断特征。

The electrodiagnostic characteristics of Glycogen Storage Disease Type III.

机构信息

Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Genet Med. 2010 Jul;12(7):440-5. doi: 10.1097/GIM.0b013e3181cd735b.

DOI:10.1097/GIM.0b013e3181cd735b
PMID:20071996
Abstract

PURPOSE

Glycogen Storage Disease Type III, also known as debrancher deficiency or Cori disease, is an autosomal recessive disorder recognized for both its hepatic and muscle manifestations. The neuromuscular manifestations of Glycogen Storage Disease Type III are not well characterized. In this study, we attempt to better define the disorder.

METHODS

The medical records of 40 patients with Glycogen Storage Disease Type III seen at Duke University during 1990-2009 were reviewed. The medical records of all patients with nerve conduction studies and/or electromyography were examined.

RESULTS

Twelve patients with Glycogen Storage Disease Type III (aged 5-55 years) had undergone nerve conduction studies +/- electromyography. Three of these cases are presented in detail. Nine patients had Glycogen Storage Disease Type IIIa, two patients had Glycogen Storage Disease Type IIIb, and the clinical subtype of one patient was unknown. All had nerve conduction studies and of those nerves tested, abnormalities in the median motor response were most common, corresponding to previously described, intrinsic hand muscle weakness. Electromyography was performed in eight patients and myopathic findings were present in six individuals. Abnormal electrodiagnostic findings were more common in older patients. The two patients with Glycogen Storage Disease Type IIIb had electrodiagnostic evidence of nerve involvement with minor myopathic findings.

CONCLUSIONS

The neuromuscular manifestations of Glycogen Storage Disease Type III include myopathy and neuropathy and are more likely to occur with increasing age, even in those diagnosed with Glycogen Storage Disease Type IIIb. Intrinsic hand muscle weakness is likely due to a combination of nerve and muscle dysfunction, a finding that may have implications for treatment.

摘要

目的

糖原贮积病 III 型,又称支链脱支酶缺乏症或科里病,是一种常同时累及肝脏和肌肉的常染色体隐性遗传病。糖原贮积病 III 型的神经肌肉表现尚未得到充分描述。本研究旨在更好地阐明其神经肌肉表现。

方法

对 1990 年至 2009 年期间在杜克大学就诊的 40 例糖原贮积病 III 型患者的病历进行了回顾性分析。对所有接受神经传导研究和/或肌电图检查的患者的病历进行了检查。

结果

12 例糖原贮积病 III 型患者(年龄 5-55 岁)接受了神经传导研究 +/-肌电图检查。其中 3 例详细介绍如下。9 例为糖原贮积病 IIIa 型,2 例为糖原贮积病 IIIb 型,1 例患者的临床亚型不详。所有患者均接受了神经传导研究,其中正中神经运动反应异常最为常见,与先前描述的手部固有肌肉无力相对应。8 例患者进行了肌电图检查,其中 6 例存在肌病表现。随着年龄的增长,神经电生理异常更为常见。2 例糖原贮积病 IIIb 型患者存在神经电生理异常和轻微肌病表现。

结论

糖原贮积病 III 型的神经肌肉表现包括肌病和神经病,且随着年龄的增长更易发生,即使在诊断为糖原贮积病 IIIb 型的患者中也是如此。手部固有肌肉无力可能是神经和肌肉功能障碍的共同结果,这一发现可能对治疗具有启示意义。

相似文献

1
The electrodiagnostic characteristics of Glycogen Storage Disease Type III.糖原贮积病 III 型的电诊断特征。
Genet Med. 2010 Jul;12(7):440-5. doi: 10.1097/GIM.0b013e3181cd735b.
2
Skeletal and cardiac muscle involvement in children with glycogen storage disease type III.III型糖原贮积病患儿的骨骼肌和心肌受累情况
Eur J Pediatr. 2015 Nov;174(11):1545-8. doi: 10.1007/s00431-015-2546-0. Epub 2015 May 7.
3
Pathological characteristics of glycogen storage disease III in skeletal muscle.骨骼肌中糖原贮积病III型的病理特征。
J Clin Neurosci. 2015 Oct;22(10):1674-5. doi: 10.1016/j.jocn.2015.03.041. Epub 2015 Jun 9.
4
[Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis].9例表现为肌无力的脱支酶缺乏症(III型糖原贮积病)——临床生化分析研究
Rinsho Shinkeigaku. 1996 Apr;36(4):540-3.
5
Clinical varieties of neuromuscular disease in debrancher deficiency.脱支酶缺乏症中的神经肌肉疾病临床类型
Arch Neurol. 1984 Oct;41(10):1027-32. doi: 10.1001/archneur.1984.04050210025008.
6
Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.III型糖原贮积病(糖原脱支酶缺乏症):生化缺陷与肌病和心肌病的相关性
Ann Intern Med. 1992 Jun 1;116(11):896-900. doi: 10.7326/0003-4819-116-11-896.
7
Neuromuscular involvement in glycogen storage disease type III.III型糖原贮积病的神经肌肉受累情况
Acta Paediatr Scand. 1986 Mar;75(2):289-96. doi: 10.1111/j.1651-2227.1986.tb10201.x.
8
Peripheral neuropathy in glycogen storage disease type III: Fact or myth?III型糖原贮积病中的周围神经病变:确有其事还是无稽之谈?
Muscle Nerve. 2016 Feb;53(2):310-2. doi: 10.1002/mus.24977. Epub 2015 Dec 29.
9
Glycogen Debrancher Enzyme Deficiency Myopathy.糖原分支酶缺乏症肌病。
J Clin Neuromuscul Dis. 2021 Jun 1;22(4):224-227. doi: 10.1097/CND.0000000000000339.
10
Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature.糖原贮积病 IIIa 型患儿的物理治疗评估及全身磁共振成像表现:临床研究及文献复习。
Mol Genet Metab. 2021 Nov;134(3):223-234. doi: 10.1016/j.ymgme.2021.10.002. Epub 2021 Oct 9.

引用本文的文献

1
A novel sequence of the PHKG2 mutation associated with the first case of glycogen storage diseases type IXc in Syria: a case report and review of literature.叙利亚首例IXc型糖原贮积病相关PHKG2突变的新序列:病例报告及文献综述
J Med Case Rep. 2025 Jul 4;19(1):317. doi: 10.1186/s13256-025-05383-z.
2
Diverse electrophysiological demyelinating features in a late-onset glycogen storage disease type IIIa case.一例晚发型Ⅲa型糖原贮积病的多种电生理脱髓鞘特征
Open Med (Wars). 2025 Apr 29;20(1):20251172. doi: 10.1515/med-2025-1172. eCollection 2025.
3
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease.
III型糖原贮积病:一项评估疾病负担的混合方法研究。
Ther Adv Endocrinol Metab. 2024 Jan 8;15:20420188231224233. doi: 10.1177/20420188231224233. eCollection 2024.
4
The multifaceted roles of the brain glycogen.脑糖原的多面角色。
J Neurochem. 2024 May;168(5):728-743. doi: 10.1111/jnc.15926. Epub 2023 Aug 9.
5
French recommendations for the management of glycogen storage disease type III.法国关于 III 型糖原贮积症管理的建议。
Eur J Med Res. 2023 Jul 24;28(1):253. doi: 10.1186/s40001-023-01212-5.
6
Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study.糖原贮积病 IIIa 患者的有氧能力和骨骼肌特征:一项观察性研究。
Orphanet J Rare Dis. 2022 Jan 31;17(1):28. doi: 10.1186/s13023-022-02184-1.
7
Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature.糖原贮积病 IIIa 型患儿的物理治疗评估及全身磁共振成像表现:临床研究及文献复习。
Mol Genet Metab. 2021 Nov;134(3):223-234. doi: 10.1016/j.ymgme.2021.10.002. Epub 2021 Oct 9.
8
Molecular Diagnosis of Panel-Based Next-Generation Sequencing Approach and Clinical Symptoms in Patients With Glycogen Storage Disease: A Single Center Retrospective Study.基于基因panel的下一代测序方法对糖原贮积病患者的分子诊断及临床症状:一项单中心回顾性研究
Front Pediatr. 2020 Dec 3;8:600446. doi: 10.3389/fped.2020.600446. eCollection 2020.
9
A novel homozygous splicing mutation of the AGL gene in a Chinese patient with severe myopathy involvement of glycogen storage disease type IIIa.
Neurol Sci. 2021 Apr;42(4):1623-1625. doi: 10.1007/s10072-020-04883-8. Epub 2020 Nov 11.
10
Natural Progression of Canine Glycogen Storage Disease Type IIIa.犬IIIa型糖原贮积病的自然病程。
Comp Med. 2016 Feb;66(1):41-51.